Overview

MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030)

Status:
Terminated
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
This study will look to see if MK0767 works better than placebo in controlling blood sugar in patients with Type 2 Diabetes who are taking insulin but do not have adequate control of their blood sugar. This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.